Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Augmentation of Antitumor Immunity by Human and Mouse CAR T Cells Secreting IL-18

Published:2017-09 Issue:13 Volume:20 Page:3025-3033
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Hu Biliang,Ren Jiangtao,Luo Yanping,Keith Brian,Young Regina M.,Scholler John,Zhao Yangbing,June Carl H.

Funder

NIH

Novartis Alliance

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference30 articles.

1. Regression of Glioblastoma after Chimeric Antigen Receptor T-Cell Therapy;Brown;N. Engl. J. Med.,2016

2. Distinct effects of IL-18 on the engraftment and function of human effector CD8 T cells and regulatory T cells;Carroll;PLoS ONE,2008

3. IL-12 release by engineered T cells expressing chimeric antigen receptors can effectively Muster an antigen-independent macrophage response on tumor cells that have shut down tumor antigen expression;Chmielewski;Cancer Res.,2011

4. Of CARs and TRUCKs: chimeric antigen receptor (CAR) T cells engineered with an inducible cytokine to modulate the tumor stroma;Chmielewski;Immunol. Rev.,2014

5. IL-12 deaths: explanation and a puzzle;Cohen;Science,1995

Cited by 351 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The potential of mesenchymal stem cell coexpressing cytosine deaminase and secretory IL18-FC chimeric cytokine in suppressing glioblastoma recurrence;International Immunopharmacology;2024-12

2. Regional and intratumoral adoptive T-cell therapy;Immuno-Oncology and Technology;2024-12

3. Advancements in adoptive CAR immune cell immunotherapy synergistically combined with multimodal approaches for tumor treatment;Bioactive Materials;2024-12

4. Igniting hope: Harnessing NLRP3 inflammasome-GSDMD-mediated pyroptosis for cancer immunotherapy;Life Sciences;2024-10

5. An integrated perspective on measuring cytokines to inform CAR-T bioprocessing;Biotechnology Advances;2024-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3